Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases.
Di Giacomo AM, Danielli R, Guidoboni M, CalabrĂ² L, Carlucci D, Miracco C, Volterrani L, Mazzei MA, Biagioli M, Altomonte M, et al. Cancer Immunol Immunother. 2009 Aug; 58(8):1297-306. Epub 2009 Jan 13.